Rare diseases
Investigational molecules
Locations
Back to Poland37 clinical trials in Peremyshl, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
PolandStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
PolandStudy of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer
PolandA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
PolandStudy Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
PolandStudy Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations
PolandStudy on the Safety and Tolerability of Abelacimab Compared to Rivaroxaban in Patients with Atrial Fibrillation
PolandStudy of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression
PolandStudy of Pembrolizumab, Vibostolimab, and Belzutifan for Patients with Metastatic Castration-Resistant Prostate Cancer
PolandStudy on Rilvegostomig and Chemotherapy for Patients with Biliary Tract Cancer After Surgery
PolandStudy of ONCOFID-P-B for Patients with Bladder Carcinoma in Situ Unresponsive to BCG Treatment
PolandStudy of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy
PolandThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) evaluating novel immunotherapy combinations and treatments. Research includes studies of advanced metastatic cases and post-surgical therapeutic approaches.
Investigating breakthrough treatments for both early-stage and advanced lung cancer patients.
Innovative research in bladder cancer treatment, particularly focusing on non-muscle invasive cases. Studies evaluate new intravesical therapies and treatment approaches for patients unresponsive to standard care.
Advanced therapeutic options for various stages of bladder cancer.
Studies addressing atrial fibrillation and cardiovascular conditions, focusing on new anticoagulation approaches and post-heart attack treatments. Research aims to improve patient outcomes and reduce complications.
Evaluating next-generation treatments for common cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
